2024-10-22 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance Comparison:**

Intuitive Surgical Inc. (ISRG) has significantly outperformed the S&P 500 (VOO) with a cumulative return of 377.54% compared to 137.88% for VOO. This represents a substantial difference of 239.66%, indicating a strong performance relative to the broader market. The relative divergence of 82.52% places ISRG within the top 90% of its historical performance range against VOO.

**2. Recent Price Movement:**

* **Closing Price:** $521.15
* **5-Day Moving Average:** $487.51
* **20-Day Moving Average:** $485.04
* **60-Day Moving Average:** $477.13

The stock is currently trading above its 5, 20, and 60-day moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 62.74 -  Indicates a moderately overbought condition.
* **PPO:** 0.3 - Positive value suggests potential upward momentum.
* **Delta_Previous_Relative_Divergence:** 6.75 - Positive value suggests recent short-term upward momentum.
* **Expected Return:** 12.36% - This represents the potential long-term (2+ years) excess return compared to the S&P 500 for a buy and hold strategy.

The technical indicators suggest that ISRG might be experiencing some near-term overbought conditions but remains in a positive momentum trajectory with a good long-term outlook.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | $2.04B |
| 2024-07-19 | 1.48 | $2.01B |
| 2024-04-19 | 1.54 | $1.89B |
| 2023-10-20 | 1.18 | $1.74B |
| 2024-10-18 | 1.18 | $1.74B |

ISRG has consistently exceeded revenue expectations in recent quarters. While the most recent earnings were not yet available, the company has a track record of robust growth and exceeding analyst expectations. 

**5. News and Recent Issues:**

* **Recent Market Outlook:**  Intuitive Surgical is considered a leader in the minimally invasive surgical market with a strong position and continued innovation. The demand for robotic-assisted surgery continues to grow, indicating a positive outlook for the company.
* **Analyst Opinions and Performance Highlights:**  Most analysts remain bullish on ISRG with price targets ranging from $550 to $650. They highlight its strong market position, consistent growth, and innovative product development.
* **Key Issues:**  Competition from other players in the robotic surgery market is a factor to consider. However, ISRGâ€™s established dominance and strong reputation likely provide it with a competitive advantage.

**6.  Overall Analysis:**

ISRG exhibits strong performance compared to the broader market with a consistent track record of exceeding revenue expectations. The company's leading position in robotic surgery and ongoing innovation create a positive outlook for the future. Technical indicators suggest potential short-term overbought conditions, but the long-term outlook remains positive. The company faces competition but its established market presence and brand recognition offer a strong competitive advantage. 

**7.  Recommendation:**

ISRG remains a compelling investment opportunity for investors seeking long-term growth and exposure to the minimally invasive surgery market. While near-term overbought conditions may warrant caution, the company's solid fundamentals and continued innovation make it a strong candidate for long-term portfolio inclusion. 
